Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03765983
Recruitment Status : Recruiting
First Posted : December 5, 2018
Last Update Posted : April 13, 2021
Sponsor:
Collaborator:
Kazia Therapeutics Limited
Information provided by (Responsible Party):
Jose Pablo Leone, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : November 30, 2025